Christopher Busayo Olowosoke

Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics

Prosper Obed Chukwuemeka, Haruna Isiyaku Umar, Opeyemi Iwaloye et al. · Journal of Biomolecular Structure and Dynamics · 2021 · 22 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond “Failure to rescue”

Prosper Obed Chukwuemeka, Haruna Isiyaku Umar, Opeyemi Iwaloye et al. · Journal of Biomolecular Structure and Dynamics · 2021 · 22 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Computer aided and experimental study of cinnamic acid analog for oxidative stress treatment: The therapeutic validations

Oluwafemi Adeleke Ojo, Oluwafemi Adeleke Ojo, Akingbolabo Daniel Ogunlakin et al. · Informatics in Medicine Unlocked · 2022 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Integrative study of phytochemicals for anti-fibroid agent: A perspective on protein networks, molecular docking, ADMET, simulation, DFT and bioactivity

Christopher Busayo Olowosoke, Chioma Joy Eze, Aqsa Munir et al. · Chemical Physics Impact · 2023 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Multi-regulator of EZH2-PPARs Therapeutic Targets: A Hallmark for Prospective Restoration of Pancreatic Insulin Production and Cancer Dysregulation

Christopher Busayo Olowosoke, Otitoola Shobi Gbemisola, Adebola Abosede Alaba et al. · Applied Biochemistry and Biotechnology · 2023 · 14 citations

Medicine, Molecular Biology, Oncology +17